Community platinum use in neoadjuvant or adjuvant HER2-breast cancer.

被引：0
|
作者：
Bobolts, Laura Rose
Armitage, Melissa
Tamayo, Mary Michelle
Hrushesky, William J.
Kogler, Jurgen
Schorer, Anna E.
Wurtz, Kenneth
Bennett, Charles L.
Shimp, William S.
Baranwal, Anmol
Huff, Dinah Faith Q.
Anthony, Carol
Walton, Robert
Fishman, Marc L.
机构：
[1] Oncol Analyt Inc, Plantation, FL USA
[2] Nova SE Univ, Coll Pharm, Ft Lauderdale, FL 33314 USA
[3] Onc Analyt, W Orange, NJ USA
[4] South Carolina Coll Pharm, Columbia, SC USA
[5] Oncol Analyt, Lonsdale, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12029
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Conventional Tools for Predicting Satisfactory Response to Neoadjuvant Chemotherapy in HR+/HER2-Breast Cancer Patients
    Oprea, Adela Luciana
    Gulluoglu, Bahadir
    Aytin, Yusuf Emre
    Eren, Ozgur Can
    Aral, Canan
    Szekely, Tiberiu-Bogdan
    Tastekin, Ebru
    Kaya, Handan
    Bademler, Sueleyman
    Karanlik, Hasan
    Sezer, Atakan
    Ugurlu, Mustafa Umit
    Turdean, Sabin Gligore
    Georgescu, Rares
    Marginean, Claudiu
    [J]. BREAST CARE, 2023, 18 (05) : 344 - 353
  • [22] Systemic treatment of breast cancer. New insights into neoadjuvant and adjuvant therapies
    Ditsch, N.
    Untch, M.
    [J]. ONKOLOGIE, 2022, 28 (01): : 77 - 87
  • [23] Neoadjuvant pembrolizumab plus decitabine followed by standard neoadjuvant chemotherapy for locally advanced HER2-breast cancer (NCT02957968)
    Bear, Harry
    Deng, Xiaoyan
    Bandyopadhyay, Dipankar
    Idowu, Michael
    Kmieciak, Maciej
    Williams, Monique
    Archer, Giovanni
    Gwaltney, Lindsey
    Dillon, Patrick
    Flora, Daniel
    Stover, Daniel
    Poklepovic, Andrew
    Hackney, Mary
    Ross, Masey
    Vachhani, Hetal
    Louie, Raphael
    McGuire, Kandace
    Grover, Amelia
    Rahman, Tasnim
    Hendrix, Amber
    [J]. CANCER RESEARCH, 2024, 84 (09)
  • [24] Use of Novel Combination Therapies in the Treatment of Advanced HR+/HER2-Breast Cancer
    Chang, Jenny C.
    O'Regan, Ruth
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 : S1 - S14
  • [25] PAM50-based ROR indexes as a tool to individualize the use of neoadjuvant endocrine therapy in ER+/HER2-breast cancer
    Lopez Velazco, J. I.
    Manzano, S.
    Elorriaga, K.
    Lahuerta Martinez, A.
    Alvarez, L. A.
    Etxabe Azkue, I.
    Huarte Martinez, M.
    Buch, E.
    Gimenez Climent, J.
    Quiroga Garcia, V.
    Aragon, S.
    Pare, L.
    Prat, A.
    Alvarez Lopez, I.
    Munoz Caffarel, M.
    Urruticoechea, A.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S168 - S169
  • [26] Factors associated with the use of adjuvant neratinib in stage I-III HER2-positive breast cancer.
    Stoen, Ericson
    Kagihara, Jodi
    Kabes, Pater
    Fisher, Christine M.
    Diamond, Jennifer Robison
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [27] Using neoadjuvant therapy response to guide adjuvant therapy in HER2+breast cancer
    Krop, I.
    [J]. BREAST, 2019, 44 : S13 - S13
  • [28] Biological and clinical effects of abemaciclib in a phase 2 neoadjuvant study for postmenopausal patients with HR+/HER2-breast cancer
    Guarneri, V.
    Fasching, P. A.
    Fernandez Abad, M.
    Garcia-Saenz, A.
    Schneeweiss, A.
    Colleoni, M.
    Petru, E.
    Costigan, T. M.
    Caldwell, C. W.
    Barriga, S.
    Hurvitz, S.
    Slamon, D.
    [J]. ANNALS OF ONCOLOGY, 2017, 28 : 19 - 19
  • [29] Biological and clinical effects of abemaciclib in a phase 2 neoadjuvant study for postmenopausal patients with HR+/HER2-breast cancer
    Fasching, P. A.
    Fernandez Abad, M.
    Garcia-Saenz, J. A.
    Schneeweiss, A.
    Guarneri, V.
    Colleoni, M.
    Petru, E.
    Costigan, T. M.
    Caldwell, C. W.
    Barriga, S.
    Hurvitz, S.
    Slamon, D.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 225 - +
  • [30] Prognostic implications of HER2 gain in patients with HR+/ HER2-breast cancer (BC) and TNBC after neoadjuvant chemotherapy (NAC)
    Ferraro, E.
    Minmin, S. Chew
    Nemirovsky, D.
    Chen, Y.
    Barrio, A. V.
    Modi, S.
    Seidman, A.
    Wen, H.
    Brogi, E.
    Robson, M.
    Dang, C.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S301 - S301
12345